Figure 2.
Positive Flow Cytometric Analysis of CXCR4 Expression on AML Myeloblast Cells. Flow cytometric analysis of CXCR4 expression on AML myeloblast cells. These results were obtained from a patient with newly diagnosed acute myeloblastic leukemia (FAB-M2 AML). CXCR4(CD184 PE) expression was measured on myeloblast populations after setting a gate on side scatter (SSC)/anti-CD45 APC scatter graph, completed with CD34 expression to optimize myeloblast gating. expression was positive in this case =84.2%.